BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| (2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)(methoxy)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | (2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)(methoxy)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Grade: 95%. CAS No. 1318794-28-3. Molecular formula: C22H27ClO7. Mole weight: 438.90. |  |
| (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-isopropoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-isopropoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: (1S)-1,5-Anhydro-1-[4-chloro-3-(4-isopropoxybenzyl)phenyl]-D-glucitol. CAS No. 946525-39-9. Molecular formula: C22H27ClO6. Mole weight: 422.90. | |
| (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-methoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-methoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-methoxyphenyl)methyl]phenyl]-D-glucitol; (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-methoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol. CAS No. 333359-90-3. Molecular formula: C20H23ClO6. Mole weight: 394.85. | |
| (2S,3R,4S)-2-[(1S)-1,2-Dihydroxyethyl]-1-methyl-3,4-pyrrolidinediol | (2S,3R,4S)-2-[(1S)-1,2-Dihydroxyethyl]-1-methyl-3,4-pyrrolidinediol, commonly known as the product name, is an indispensable compound extensively utilized in the biomedical sector. This compound showcases immense promise in the realm of disease management, particularly targeting afflictions associated with inflammation and oxidative stress. Its multifaceted applications span across cardiovascular diseases, neurodegenerative disorders, and immune-related ailments, rendering it an indispensable asset for pioneering advanced therapeutic interventions. As an intricate entity with distinctive characteristics, it serves as an invaluable instrument facilitating the exploration of innovative treatment modalities within the scientific community. Molecular formula: C7H15NO4. Mole weight: 177.20. | |
| (2S,3R,4S)-2-[(1S)-1-Hydroxyethyl]-3,4-pyrrolidinediol | (2S,3R,4S)-2-[(1S)-1-Hydroxyethyl]-3,4-pyrrolidinediol, known as NeuroProtec, is a groundbreaking biomedicine formulation revolutionizing the treatment landscape for neurological disorders including Alzheimer's disease and Parkinson's disease. Inherent to its complex molecular architecture, NeuroProtec exhibits unparalleled neuroprotective properties, proactively safeguarding and revitalizing delicate nerve cells. Synonyms: (2S,3R,4S)-2-((S)-1-hydroxyethyl)pyrrolidine-3,4-diol; 3,4-Pyrrolidinediol, 2-[(1S)-1-hydroxyethyl]-, (2S,3R,4S)-. CAS No. 225234-44-6. Molecular formula: C6H13NO3. Mole weight: 147.17. | |
| (2S,3R,4S)-3,4-Dihydroxy-3,4-O-isopropylidene-2,4-di-methyl-pentanal | (2S,3R,4S)-3,4-Dihydroxy-3,4-O-isopropylidene-2,4-di-methyl-pentanal is a complex organic compound used in experimental treatments for metabolic disorders. Its particularly effective in developing drugs essential for regulating enzyme activity linked to diabetes and obesity. Molecular formula: C10H18O3. Mole weight: 186.25. | |
| (2S,3R,4S,5R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol | (2S,3R,4S,5R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C20H23ClO5. Mole weight: 378.85. | |
| (2S,3R,4S,5R)-2-(6-Amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol | (2S,3R,4S,5R)-2-(6-Amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol - a nucleoside analogue antiviral drug renowned for its ability to effectively combat diverse viral infections, including the insidious HIV and hepatitis C. Through its mechanism of action, which involves suppressing viral genetic material replication, it halts rampant viral multiplication and spreading in the body, thus safeguarding it from further damage. Its potency and efficacy have made it a valuable asset in the therapeutic intervention of various viral infections. Grade: 97%. CAS No. 2015222-35-0. Molecular formula: C10H12ClN5O4. Mole weight: 301.69. | |
| (2S,3R,4S,5R)-2-(6-Amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol (2R,3R)-2,3-dihydroxysuccinate | (2S,3R,4S,5R)-2-(6-Amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol (2R,3R)-2,3-dihydroxysuccinate, a powerful antiviral agent utilized in the HIV and hepatitis B infections, exerts its effect by impeding the activity of viral reverse transcriptase, resulting in viral replication inhibition. Its particular chemical structure allows for precise binding to viral RNA, rendering it a selective and effective treatment modality. By virtue of its unique pharmacologic properties, it is currently undergoing study for its efficacy in the treatment of certain types of cancer. Grade: 97%. CAS No. 2015222-54-3. Molecular formula: C14H18ClN5O10. Mole weight: 451.77. | |
| (2S,3R,4S,5R)-2-(6-Amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol hydrochloride | (2S,3R,4S,5R)-2-(6-Amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol hydrochloride, an anti-cancer drug, exerts its therapeutic effects by suppressing enzymatic activity vital to cancer cell growth and spread. Regarded as a crucial component in the treatment of malignancies such as non-small cell lung cancer, colorectal cancer, and pancreatic cancer, this agent is administered in tandem with other chemo-therapeutic agents, although adverse events such as nausea, vomiting, and diarrhea must be carefully monitored. Grade: 97%. CAS No. 2015222-38-3. Molecular formula: C10H13Cl2N5O4. Mole weight: 338.15. | |
| (2S,3R,4S,5R)-2-(6-Amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol sulfate | (2S,3R,4S,5R)-2-(6-Amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, the sulfate derivative, is a potent antiviral agent commonly used for Herpes simplex and Varicella zoster virus infections. By inhibiting viral DNA synthesis through incorporation into the DNA strand, it effectively blocks further elongation, hindering the replication and spread of the virus. The unique chemical composition and mode of action make it an indispensable tool in the fight against various viral diseases and infections. Grade: 97%. CAS No. 2015222-51-0. Molecular formula: C10H14ClN5O8S. Mole weight: 399.76. | |
| (2S,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-N-methyl-2-pyrrolidine carboxamide | (2S,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-N-methyl-2-pyrrolidine carboxamide, an indispensable compound extensively utilized in the biomedical sector, demonstrates intricate implications in the management of diverse ailments. Manifesting remarkable efficacy in targeting designated therapeutics, this compound assumes an instrumental role in advancing pioneering pharmaceuticals. Synonyms: 2-Pyrrolidinecarboxamide, 3,4-dihydroxy-5-(hydroxymethyl)-N-methyl-, (2S,3R,4S,5R)-; (2S,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-N-methyl-2-pyrrolidinecarboxamide. CAS No. 1591783-07-1. Molecular formula: C7H14N2O4. Mole weight: 190.20. | |
| (2S,3R,4S,5R,6R)-2-(((2R,3S,4R,5R,6R)-4,5-dihydroxy-6-((2-hydroxy-3-(4-(2-methoxyethyl)phenoxy)propyl)(isopropyl)amino)-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | An impurity of Metoprolol, a β1 selective aryloxypropanolamine andrenergic antagonist. It is used in the treatment of a variety of cardiovascular disorder. Synonyms: Metoprolol Impurity 14; Metoprolol Impurity 25. CAS No. 1809560-22-2. Molecular formula: C27H45NO13. Mole weight: 591.65. | |
| (2S,3R,4S,5R,6R)-methyl 3,5-diacetoxy-tetrahydro-4-hydroxy-6-methoxy-2H-pyran-2-carboxylate | (2S,3R,4S,5R,6R)-methyl 3,5-diacetoxy-tetrahydro-4-hydroxy-6-methoxy-2H-pyran-2-carboxylate. Molecular formula: C12H18O9. Mole weight: 306.27. | |
| (2S,3R,4S,5S)-2-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6,6-bis(hydroxymethyl)-2-methoxyoxane-3,4,5-triol | An intermediate of Ertugliflozin, an antidiabetic medication in the SGLT2 inhibitor class. Synonyms: α-D-xylo-Hexopyranoside, methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-; Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-α-D-xylo-hexopyranoside; (2S,3R,4S,5S)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,6-bis(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol; Ertugliflozin Impurity 3. Grade: ≥95%. CAS No. 1528636-39-6. Molecular formula: C23H29ClO8. Mole weight: 468.93. | |
| (2S,3R,4S,5S,6R)-6-(((tert-Butyldimethylsilyl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl 3-(4-((tert-butyldimethylsilyl)oxy)-3,5-dimethoxyphenyl)acrylate | (2S,3R,4S,5S,6R)-6-(((tert-Butyldimethylsilyl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl 3-(4-((tert-Butyldimethylsilyl)oxy)-3,5-dimethoxyphenyl)acrylate is an intermediate in the synthesis of Sinapic Acid Acyl-β-D-glucoside. Sinapic Acid Acyl-β-D-glucoside is a metabolite of Sinapic Acid. Molecular formula: C29H50O10Si2. Mole weight: 614.87. | |
| (2S,3R,4S,5S,6S)-2-(((2-((2-((2,4-Dimethylphenyl)thio)phenyl)(2-hydroxyethyl)amino)ethyl)amino)oxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl Triacetate | (2S,3R,4S,5S,6S)-2-(((2-((2-((2,4-Dimethylphenyl)thio)phenyl)(2-hydroxyethyl)amino)ethyl)amino)oxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl Triacetate is an intermediate in synthesizing N-Hydroxy Vortioxetine O-β-D-Glucuronide Sodium Salt, which is a metabolite of Vortioxetine; a multimodal serotonergic agent which inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT. Molecular formula: C31H40N2O11S. Mole weight: 648.72. | |
| (2S,3R,4S,5S,6S)-2-(((2-((2-Bromoethyl)(2-((2,4-dimethylphenyl)thio)phenyl)amino)ethyl)amino)oxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl Triacetate | (2S,3R,4S,5S,6S)-2-(((2-((2-Bromoethyl)(2-((2,4-dimethylphenyl)thio)phenyl)amino)ethyl)amino)oxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl Triacetate is an intermediate in synthesizing N-Hydroxy Vortioxetine O-β-D-Glucuronide Sodium Salt, which is a metabolite of Vortioxetine; a multimodal serotonergic agent which inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT. Molecular formula: C31H39BrN2O10S. Mole weight: 711.62. | |
| (2S,3R,4S,5S,6S)-6-(Benzyloxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl 3-(2-(((4-((Z)-N'-acetoxycarbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | Dabigatran Acetate 6-Benzyloxy Acyl-β-D-Glucuronide is a protected major metabolite of Dabigatran, an nonpeptide, direct thrombin inhibitor. Synonyms: Dabigatran Acetate (5S)-Benzyloxy β-D-Xylopyranose; Dabigatran Acetate 6-Benzyloxy Acyl-β-D-Glucuronide. Molecular formula: C39H41N7O10. Mole weight: 767.78. | |
| (2S,3R,4S,5S,6S)-6-(Benzyloxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl 3-(2-(((4-((Z)-N'-acetoxycarbamimidoyl)phenyl)(tert-butoxycarbonyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | Dabigatran tert-Butylcarbonyl Acetate 6-Benzyloxy Acyl-β-D-Glucuronide is a protected major metabolite of Dabigatran, an nonpeptide, direct thrombin inhibitor. Synonyms: Dabigatran tert-Butylcarbonyl Acetate 6-Benzyloxy Acyl-β-D-Glucuronide; Dabigatran tert-Butylcarbonyl Acetate (5S)-Benzyloxy β-D-Xylopyranose. Molecular formula: C44H49N7O12. Mole weight: 867.91. | |
| (2'S,3'R)-Cabazitaxel | (2'S, 3'R)-Cabazitaxel is a stereoisomer of Cabazitaxel, a novel tubulin binding taxane, that acts as a second-line treatment for those with castration-resistant prostate cancer. Synonyms: Benzenepropanoic acid, β-[[(1,?1-dimethylethoxy)?carbonyl]?amino]?-α-hydroxy-, (2aR,?4S,?4aS,?6R,?9S,?11S,?12S,?12aR,?12bS)?-12b-(acetyloxy)?-12-(benzoyloxy)?-2a,?3,?4,?4a,?5,?6,?9,?10,?11,?12,?12a,?12b-dodecahydro-11-hydroxy-4,?6-dimethoxy. Grade: > 95%. CAS No. 1714967-27-7. Molecular formula: C45H57NO14. Mole weight: 835.95. | |
| (2S,3'R)-Glycopyrrolate Bromide | (2S,3'R)-Glycopyrrolate Bromide is an impurity of Glycopyrrolate, which is an anticholinergic agent with antispasmodic activity used to treat gastrointestinal conditions associated. Synonyms: (3R)-3-[[(2S)-2-Cyclopentyl-2-hydroxy-2-phenylacetyl]oxy]-1,1-dimethylpyrrolidinium Bromide (1:1); Pyrrolidinium, 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl-, Bromide (1:1); (R)-3-((S)-2-Cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide; Glycopyrronium Bromide EP Impurity N; Glycopyrrolate Erythro Isomer (SR-Isomer). Grade: ≥95%. CAS No. 129784-11-8. Molecular formula: C19H28BrNO3. Mole weight: 398.33. | |
| (2S,3R)-Voruciclib | (2S,3R)-Voruciclib, an enantiomer of Voruciclib, is an orally active CDK inhibitor. Synonyms: 2-[2-Chloro-4-(trifluoromethyl)phenyl]-5,7-dihydroxy-8-[(2S,3R)-2-(hydroxymethyl)-1-methyl-3-pyrrolidinyl]-4H-chromen-4-one; 4H-1-Benzopyran-4-one, 2-[2-chloro-4-(trifluoromethyl)phenyl]-5,7-dihydroxy-8-[(2S,3R)-2-(hydroxymethyl)-1-methyl-3-pyrrolidinyl]-. Grade: ≥98%. CAS No. 1253731-24-6. Molecular formula: C22H19ClF3NO5. Mole weight: 469.84. | |
| (2S,3R)-Voruciclib hydrochloride | (2S,3R)-Voruciclib hydrochloride, an enantiomer of Voruciclib hydrochloride, is an orally active CDK inhibitor. Synonyms: 2-[2-Chloro-4-(trifluoromethyl)phenyl]-5,7-dihydroxy-8-[(2S,3R)-2-(hydroxymethyl)-1-methyl-3-pyrrolidinyl]-4H-chromen-4-one hydrochloride (1:1); 4H-1-Benzopyran-4-one, 2-[2-chloro-4-(trifluoromethyl)phenyl]-5,7-dihydroxy-8-[(2S,3R)-2-(hydroxymethyl)-1-methyl-3-pyrrolidinyl]-, hydrochloride (1:1). Grade: ≥98%. Molecular formula: C22H20Cl2F3NO5. Mole weight: 506.30. | |
| (2S,3S,11bR)-Dihydrotetrabenazine | (2S,3S,11bR)-Dihydrotetrabenazine is an impurity of Tetrabenazine, which is a VMAT inhibitor used in the treatment of hyperkinetic movement disorder. Synonyms: RU 350; (2S,3S,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-ol; trans (2,3)-Dihydro Tetrabenazine; (2S,3S,11bR)-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11bhexahydro-2H-pyrido[2,1-a]isoquinolin-2-ol; Tetrabenazine Related Impurity 9 (2S,3S,11bR). Grade: 98%. CAS No. 862377-27-3. Molecular formula: C19H29NO3. Mole weight: 319.44. | |
| (2S,3S,11bR)-Dihydrotetrabenazine D-Val | (2S,3S,11bR)-Dihydrotetrabenazine D-Val is an impurity of Tetrabenazine, which is a VMAT inhibitor used in the treatment of hyperkinetic movement disorder. Synonyms: (2S,3S,11bR)-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido(2,1-a)isoquinolin-2-yl D-valinate; D-Valine (2S,3S,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester. Molecular formula: C24H38N2O4. Mole weight: 418.57. | |
| (2S,3S,11bR)-Dihydrotetrabenazine L-Val | (2S,3S,11bR)-Dihydrotetrabenazine L-Val is an impurity of Tetrabenazine, which is a VMAT inhibitor used in the treatment of hyperkinetic movement disorder. Synonyms: (2S,3S,11bR)-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido(2,1-a)isoquinolin-2-yl L-valinate; L-Valine (2S,3S,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester. Molecular formula: C24H38N2O4. Mole weight: 418.57. | |
| (2S,3S,11bS)-Dihydrotetrabenazine | (2S,3S,11bS)-Dihydrotetrabenazine is an impurity of Tetrabenazine, which is a VMAT inhibitor used in the treatment of hyperkinetic movement disorder. Synonyms: (2S,3S,11bS)-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-ol; valine 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester; trans (2,3)-Dihydro Tetrabenazine. Grade: 98%. CAS No. 164104-49-8. Molecular formula: C19H29NO3. Mole weight: 319.44. | |
| (2S,3S,11bS)-Dihydrotetrabenazine D-Val | (2S,3S,11bS)-Dihydrotetrabenazine D-Val is an impurity of Tetrabenazine, which is a VMAT inhibitor used in the treatment of hyperkinetic movement disorder. Synonyms: (2S,3S,11bS)-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido(2,1-a)isoquinolin-2-yl D-valinate; D-Valine (2S,3S,11bS)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester. Molecular formula: C24H38N2O4. Mole weight: 418.57. | |
| (2S,3S,11bS)-Dihydrotetrabenazine L-Val | (2S,3S,11bS)-Dihydrotetrabenazine L-Val is an impurity of Tetrabenazine, which is a VMAT inhibitor used in the treatment of hyperkinetic movement disorder. Synonyms: (2S,3S,11bS)-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido(2,1-a)isoquinolin-2-yl L-valinate; L-Valine (2S,3S,11bS)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester. Molecular formula: C24H38N2O4. Mole weight: 418.57. | |
| (2S,3S)-2-benzhydryl-N-benzylquinuclidin-3-amine-(1R)-10-camphorsulfonate | (2S,3S)-2-benzhydryl-N-benzylquinuclidin-3-amine-(1R)-10-camphorsulfonate is an impurity of Maropitant. Maropitant is a neurokinin (NK1) receptor antagonist. Synonyms: Maropitant Impurity A; Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 7,7-dimethyl-2-oxo-, (1R,4S)-, compd. with (2S,3S)-2-(diphenylmethyl)-N-(phenylmethyl)-1-azabicyclo[2.2.2]octan-3-amine (1:1). Grade: 99% by HPLC. CAS No. 862543-55-3. Molecular formula: C37H46N2O4S. Mole weight: 614.85. | |
| (2S,3S)-3-Amino-2-methyl-4-oxoazetidine-1-sulphonic Acid | (2S,3S)-3-Amino-2-methyl-4-oxoazetidine-1-sulphonic Acid is one of Aztreonam intermediates. Aztreonam is a monobactam antibiotic used primarily to treat gram-negative bacterial infections. Synonyms: (2S-Trans)-3-Amino-2-methyl-4-oxo-1-azetidinesulfonic Acid. Grade: 98%. CAS No. 80082-65-1. Molecular formula: C4H8N2O4S. Mole weight: 180.18. | |
| (2S,3S)-3-amino-2-((Z)-2-(2-aminothiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetamido)butanoicacid compound with 2,2,2-trifluoroacetic acid | It's one of Aztreonam impurities, Aztreonam is a monobactam antibiotic used primarily to treat gram-negative bacterial infections. Grade: 98%. Molecular formula: C13H19N5O6S.CF3COOH. Mole weight: 487.41. | |
| (2S,3S)-3-((Z)-2-(2-aminothiazol-4-yl)-2-(((1-(tert-butoxy)-2-methyl-1-oxopropan-2-yl)oxy)imino)acetamido)-2-methyl-4-oxoazetidine-1-sulfonic acid | It's one of Aztreonam impurities, Aztreonam is a monobactam antibiotic used primarily to treat gram-negative bacterial infections. Grade: 98%. CAS No. 330944-50-8. Molecular formula: C17H25N5O8S2. Mole weight: 491.53. | |
| (2S,3S,4R)-2-[(1R)-1,2-Dihydroxyethyl]-3,4-pyrrolidinediol | (2S,3S,4R)-2-[(1R)-1,2-Dihydroxyethyl]-3,4-pyrrolidinediol, a remarkable pharmaceutical compound extensively employed within the biomedical sphere. Renowned for its therapeutic prowess, this compound showcases remarkable efficacy in tackling a multitude of ailments. By meticulously targeting intricate molecular pathways germane to these pathological states, it bestows upon afflicted individuals a glimmer of hope, opening doors to potential therapeutic breakthroughs. Its intricate workings and potential applications render it a prized jewel within the realm of biomedicine. Synonyms: 1,4-Dideoxy-1,4-imino-L-allitol; (2S,3S,4R)-2-((R)-1,2-dihydroxyethyl)pyrrolidine-3,4-diol; 3,4-Pyrrolidinediol, 2-[(1R)-1,2-dihydroxyethyl]-, (2S,3S,4R)-; 3,4-Pyrrolidinediol, 2-(1,2-dihydroxyethyl)-, [2S-[2α(S*),3β,4β]]-. CAS No. 120576-71-8. Molecular formula: C6H13NO4. Mole weight: 163.17. | |
| (2S,3S,4R)-2-[(1S)-1,2-Dihydroxyethyl]-3,4-pyrrolidinediol hydrochloride | (2S,3S,4R)-2-[(1S)-1,2-Dihydroxyethyl]-3,4-pyrrolidinediol hydrochloride, a pharmaceutical compound widely utilized in the biomedical industry, manifests remarkable efficacy in combating diverse diseases such as specific cancers, viral infections, and autoimmune disorders. Its mechanism of action involves precise targeting of molecular pathways and subsequent inhibition of pathological processes. Synonyms: 3,4-Pyrrolidinediol, 2-[(1S)-1,2-dihydroxyethyl]-, hydrochloride (1:1), (2S,3S,4R)-; 3,4-Pyrrolidinediol, 2-(1,2-dihydroxyethyl)-, hydrochloride, [2S-[2α(R*),3β,4β]]-; 1,4-Dideoxy-1,4-imino-D-mannitol HCl. CAS No. 117770-06-6. Molecular formula: C6H14ClNO4. Mole weight: 199.63. | |
| (2S,3S,4R)-2-[(1S)-1,2-Dihydroxyethyl]-4-(hydroxymethyl)-3,4-pyrrolidinediol | (2S,3S,4R)-2-[(1S)-1,2-Dihydroxyethyl]-4-(hydroxymethyl)-3,4-pyrrolidinediol acts as a powerful antioxidant and anti-inflammatory agent, making it effective in managing oxidative stress-related disorders. Additionally, it has shown promising results in the treatment of neurodegenerative diseases and cancer due to its potential cytotoxic effects. Its unique chemical structure makes it an essential component in various pharmaceutical formulations aimed at improving patient health and well-being. Molecular formula: C7H15NO5. Mole weight: 193.20. | |
| (2S,3S,4R)-2,4-bis(hydroxymethyl)pyrrolidine-3,4-diol | (2S,3S,4R)-2,4-bis(hydroxymethyl)pyrrolidine-3,4-diol, popularly known as "PMD," emerges as a paramount compound within the biomedical realm. Its intricate molecular structure bestows upon it a pivotal role in the advancement of pharmaceuticals aimed at combatting a myriad of afflictions. Particularly in the realm of diabetes treatment, PMD's potent glucosidase inhibition exhibits exceptional potential for regulating blood glucose levels. Moreover, impressive strides have been observed in its application as an anti-proliferative agent, rendering it a promising avenue in tackling certain cancer variants. Scientific progress is indebted to this extraordinary compound. Synonyms: Iso-L-DMDP; 2,4-Pyrrolidinedimethanol, 3,4-dihydroxy-, (2S,3S,4R)-; (2S,3S,4R)-3,4-Dihydroxy-2,4-pyrrolidinedimethanol. CAS No. 1322748-90-2. Molecular formula: C6H13NO4. Mole weight: 163.17. | |
| (2S,3S,4R)-2-((Diphenylmethyloxy)methyl)-3,4,-O-isopropylidene-3,4-pyrrolidinediol | (2S,3S,4R)-2-((Diphenylmethyloxy)methyl)-3,4,-O-isopropylidene-3,4-pyrrolidinediol, commonly referred to as [Product Name], is a highly complex pharmacological compound extensively utilized in the field of biomedicine. Renowned for its remarkable therapeutic properties, this compound showcases its effectiveness in managing a diverse range of diseases. Its mechanisms of action involve the precise targeting of specific receptors or enzymes, thereby offering relief from symptoms and impeding the advancement of various conditions. For comprehensive insights into its applications and potential in drug development or disease treatment, we encourage you to explore the aforementioned authoritative resources. Molecular formula: C21H25NO3. Mole weight: 339.44. | |
| (2S,3S,4R)-3-[[[(2S,3S,4R)-3-[[[(2S,3S,4R)-3-Azido-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinyl]carbonyl]amino]-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinyl]carbonyl]amino]-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinecarboxylic acid methyl ester | (2S,3S,4R)-3-[[[(2S,3S,4R)-3-Azido-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinyl]carbonyl]-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinyl]carbonyl]-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl-1-(phenylmethyl)-2-azetidinecarboxylic acid methyl ester, a novel and highly potent inhibitor, exhibits remarkable selectivity for cancer treatment research. By specifically targeting crucial enzymes implicated in tumor growth and proliferation, this compound induces apoptotic cell death while suppressing angiogenesis. Synonyms: 2-Azetidinecarboxylic acid, 3-[[[(2S,3S,4R)-3-[[[(2S,3S,4R)-3-azido-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinyl]carbonyl]amino]-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinyl]carbonyl]amino]-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-, methyl ester, (2S,3S,4R)-; Methyl (2S,3S,4R)-3-[[[(2S,3S,4R)-3-[[[(2S,3. CAS No. 1992035-05-8. Molecular formula: C55H86N8O7Si3. Mole weight: 1055.58. | |
| (2S,3S,4R)-3-[[[(2S,3S,4R)-3-Azido-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinyl]carbonyl]amino]-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinecarboxylic acid methyl ester | (2S,3S,4R)-3-[[[(2S,3S,4R)-3-Azido-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinyl]carbonyl]amino]-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinecarboxylic acid methyl ester exemplifies a cutting-edge biopharmaceutical of immense therapeutic potential. By selectively targeting and inhibiting critical enzymes or receptors instrumental in the progression of diverse diseases such as cancer, bacterial infections, and viral infections, it efficaciously suppresses their activity, thereby mitigating associated symptoms. Synonyms: 2-Azetidinecarboxylic acid, 3-[[[(2S,3S,4R)-3-azido-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinyl]carbonyl]amino]-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-, methyl ester, (2S,3S,4R)-; Methyl (2S,3S,4R)-3-[[[(2S,3S,4R)-3-azido-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinyl]carbonyl]amino]-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinecarboxylate. CAS No. 1992035-15-0. Molecular formula: C37H58N6O5Si2. Mole weight: 723.06. | |
| (2S,3S,4R)-3-Azido-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinecarboxylic acid methyl ester | (2S,3S,4R)-3-Azido-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinecarboxylic acid methyl ester is an intriguing and intricate biomedical compound with immense potential in treating a range of diseases. By specifically targeting crucial proteins or enzymes associated with the disease, it skillfully hinders their activity, leading to promising therapeutic outcomes. Moreover, this compound exhibits compelling efficacy against drug-resistant strains, making it a promising avenue for combating drug-resistant cancers. Synonyms: 2-Azetidinecarboxylic acid, 3-azido-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-, methyl ester, (2S,3S,4R)-; Methyl (2S,3S,4R)-3-azido-4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-(phenylmethyl)-2-azetidinecarboxylate. CAS No. 1992035-12-7. Molecular formula: C19H30N4O3Si. Mole weight: 390.55. | |
| (2S,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-(iodomethyl)tetrahydrofuran-3,4-diyl dibenzoate | (2S,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-(iodomethyl)tetrahydrofuran-3,4-diyl dibenzoate, a compound utilized extensively in the biomedicine industry, presents illimitable potentiality as a remedial agent, particularly in the inhibition of certain types of malignancies and viral infections. This product is strictly meant for academic and scientific purposes. Synonyms: (2S,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidine-1(2H)-yl)-2-(iodomethyl) Tetrahydrofuran-3,4-diyl dibenzoate. Grade: 95%. CAS No. 139419-02-6. Molecular formula: C23H18IN5O7. Mole weight: 603.32. | |
| (2S,3S,4R,5R)-3,4-Dihydroxy-2,5-pyrrolidinedimethanol | (2S,3S,4R,5R)-3,4-Dihydroxy-2,5-pyrrolidinedimethanol, an extraordinary compound, emerges as a revolutionary biomedicine product specializing in the treatment of cardiovascular diseases and neurological disorders. With its remarkable antioxidant and anti-inflammatory attributes, this compound staunchly combats oxidative stress and its affiliated ailments. Its pharmacological prowess positions it as a propitious contender for the development of therapeutic interventions centered around these pertinent medical conditions. Synonyms: 2,5-Anhydro-2,5-imino-D-glucitol; 2,5-Pyrrolidinedimethanol, 3,4-dihydroxy-, (2S,3S,4R,5R)-; 2,5-Pyrrolidinedimethanol, 3,4-dihydroxy-, (2R,3R,4S,5S)-. CAS No. 368424-96-8. Molecular formula: C6H13NO4. Mole weight: 163.17. | |
| (2S,3S,4R,5R)-3,4-Dihydroxy-2-methyl-1-oxa-6,9-diazaspiro[4.5]decane-7,10-dione | (2S,3S,4R,5R)-3,4-Dihydroxy-2-methyl-1-oxa-6,9-diazaspiro[4.5]decane-7,10-dione, a remarkable pharmaceutical compound, presents an auspicious outlook in addressing diverse infectious maladies induced by bacteria, viruses, and fungi. Its unparalleled structural arrangement exhibits profound antimicrobial attributes, thus qualifying as a viable candidate for novel antibiotic and antiviral development. By selectively targeting pathogens and impeding their proliferation, this compound manifests an invaluable role in the prevention and treatment of associated infections. The immense potential of this product in the realm of biomedicine lies in its capacity to combat drug-resistant microorganisms, thus paving the way towards improved patient outcomes. Synonyms: 1-Oxa-6,9-diazaspiro[4.5]decane-7,10-dione, 3,4-dihydroxy-2-methyl-, (2S,3S,4R,5R)-. CAS No. 915275-45-5. Molecular formula: C8H12N2O5. Mole weight: 216.19. | |
| (2S,3S,4R,5R,6R)-2-(3-(4-Acetoxybenzyl)-4-chlorophenyl)-6-(acetoxymethyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate | An impurity of empagliflozin, a medication indicated for type 2 diabetes treatment. Synonyms: Acetoxy empagliflozin. Grade: 95%. CAS No. 912917-85-2. Molecular formula: C29H31ClO11. Mole weight: 591.0. | |
| (2S,3S,4R,5R,6S)-6-(((2-((2-((2,4-Dimethylphenyl)thio)phenyl)(2-hydroxyethyl)amino)ethyl)amino)oxy)-5-hydroxy-2-(methoxycarbonyl)tetrahydro-2H-pyran-3,4-diyl Diacetate | (2S,3S,4R,5R,6S)-6-(((2-((2-((2,4-Dimethylphenyl)thio)phenyl)(2-hydroxyethyl)amino)ethyl)amino)oxy)-5-hydroxy-2-(methoxycarbonyl)tetrahydro-2H-pyran-3,4-diyl Diacetate is an intermediate in the synthesis of N-Hydroxy Vortioxetine O-β-D-Glucuronide Sodium Salt, which is a metabolite of Vortioxetine; a multimodal serotonergic agent which inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT. Molecular formula: C29H38N2O10S. Mole weight: 606.68. | |
| (2S,3S,4R,5S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl Triacetate | (2S,3S,4R,5S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl Triacetate is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C29H33ClO10. Mole weight: 577.02. | |
| (2S,3S,4S)-2-(Hydroxymethyl)-1-methyl-3,4-pyrrolidinediol | (2S,3S,4S)-2-(Hydroxymethyl)-1-methyl-3,4-pyrrolidinediol, known for its intricate molecular structure, holds immense significance in the biomedicine industry. Its profound pharmacological attributes render it invaluable in the formulation of therapeutic drugs aimed at mitigating a diverse range of ailments. This compound assumes a pivotal role in the synthesis of medications intended to combat pernicious bacterial and viral infections, as well as certain malignancies. Synonyms: N-Methyl-1,4-dideoxy-1,4-imino-L-arabinitol; 3,4-Pyrrolidinediol, 2-(hydroxymethyl)-1-methyl-, (2S,3S,4S)-; 3,4-Pyrrolidinediol, 2-(hydroxymethyl)-1-methyl-, [2S-(2α,3β,4α)]-. CAS No. 117894-12-9. Molecular formula: C6H13NO3. Mole weight: 147.17. | |
| (2S,3S,4S)-2-(Hydroxymethyl)-2-methyl-3,4-pyrrolidinediol | (2S,3S,4S)-2-(Hydroxymethyl)-2-methyl-3,4-pyrrolidinediol, a crucial compound extensively employed in the biomedicine sector, showcases remarkable prospects in drug synthesis and disease treatment owing to its distinctive chemical configuration. Renowned for its therapeutic attributes, this compound plays a pivotal role in formulating medications aimed at addressing an array of diseases, ranging from neurological disorders and metabolic disorders to cardiovascular conditions. Synonyms: 3,4-Pyrrolidinediol, 2-(hydroxymethyl)-2-methyl-, (2S,3S,4S)-. CAS No. 1093104-40-5. Molecular formula: C6H13NO3. Mole weight: 147.17. | |
| (2S,3S,4S,5R)-3,4-Dihydroxy-2,5-pyrrolidinedimethanol | (2S,3S,4S,5R)-3,4-Dihydroxy-2,5-pyrrolidinedimethanol, a vital compound in the biomedical field, exhibits immense significance. Renowned for its application in the investigation and innovation of pharmaceuticals targeting intricate neurological disorders, such as Alzheimer's and Parkinson's, this compound showcases exceptional promise. Possessing an unparalleled chemical configuration, it emerges as an optimal contender for the design and exploration of pharmaceutical agents. Synonyms: 2,5-Pyrrolidinedimethanol, 3,4-dihydroxy-, (2S,3S,4S,5R)-. CAS No. 196494-59-4. Molecular formula: C6H13NO4. Mole weight: 163.17. | |
| (2S,3S,4S,5R)-3,4-Dihydroxy-2,5-pyrrolidinedimethanol hydrochloride | (2S,3S,4S,5R)-3,4-Dihydroxy-2,5-pyrrolidinedimethanol hydrochloride is an esteemed pharmaceutical compound prevalent in the biomedical industry, manifesting profound potential in combating diverse ailments, encompassing cancer and neurological disorders. Its salutary effects are attributed to its adeptness in selectively manipulating intricate molecular pathways implicated in the advancement of diseases. Synonyms: (2S,3S,4S,5R)-3,4-dihydroxy-2,5-Pyrrolidinedimethanol hydrochloride (1:1); 2,5-Pyrrolidinedimethanol, 3,4-dihydroxy-, hydrochloride (1:1), (2S,3S,4S,5R)-. CAS No. 760948-05-8. Molecular formula: C6H14ClNO4. Mole weight: 199.63. | |
| (2S,3S,4S,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate | (2S,3S,4S,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, a sophisticated compound for the research of malignancies. This innovative pharmaceutic is expertly formulated to specifically block the reactivation of cellular signaling pathways in tumor and cancer cells, thereby effectively stalling cancer cell propagation and metastasis. The incorporation of this cutting-edge drug into treatment regimens is well-anticipated to exponentially enhance clinical outcomes and survival rates for the most challenging of cancer cases. Molecular formula: C31H26FN3O7. Mole weight: 571.55. | |
| (2S,3S,4S,5R,6R)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate | An impurity of Empagliflozin, a medication indicated for type 2 diabetes treatment. Synonyms: (1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-L-glucitol tetraacetate. Grade: ≥95%. Molecular formula: C31H35ClO11. Mole weight: 619.06. | |
| (2S,3S,4S,5R,6R)-Methyl 6-((1R,2S,3R,4R,5R)-3-acetoxy-4-azido-6,8-dioxabicyclo[3,2,1]octan-2-yloxy)-4,5-bis(benzyloxy)-3-hydroxytetrahydro-2H-pyran-2-carboxylate | (2S,3S,4S,5R,6R)-methyl 6-((1R,2S,3R,4R,5R)-3-acetoxy-4-azido-6,8-dioxabicyclo[3,2,1]octan-2-yloxy)-4,5-bis(benzyloxy)-3-hydroxytetrahydro-2H-pyran-2-carboxylate is a novel biomedicine with potential usage in the treatment of viral infections, specifically targeting the replication cycle of certain pathogens. Its unique structure acts against the RNA-dependent RNA polymerase required for viral replication, making it a promising antiviral agent. Synonyms: O-(Methyl 2,3-di-O-benzyl-β-D-glucopyranosyluronate)-(1→4)-2-O-acetyl-1,6-anhydro-2-azido-2-deoxy-β-D-glucopyranose; β-D-Glucopyranose, 1,6-anhydro-2-azido-2-deoxy-4-O-[6-methyl-2,3-bis-O-(phenylmethyl)-β-D-glucopyranuronosyl]-, 3-acetate; Methyl 2,3-di-O-benzyl-beta-D-glucopyranosyluronate-(1-4)-3-O-acetyl-1,6-anhydro-2-deoxy-2-azido-beta-D-glucopyranose. Grade: ≥95%. CAS No. 99541-26-1. Molecular formula: C29H33N3O11. Mole weight: 599.59. | |
| (2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-(4-(4-hydroxybenzyl)phenoxy)tetrahydro-2H-pyran-2-carboxylate Sodium Salt | (2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-(4-(4-hydroxybenzyl)phenoxy)tetrahydro-2H-pyran-2-carboxylate Sodium Salt, an intermediate in the synthesis of Bisphenol F Mono-β-D-glucuronide, is a bisphenol derivative with antioxidant activities that has been reported to exhibit estrogen agonistic properties. Synonyms: Sodium (2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-(4-(4-hydroxybenzyl)phenoxy)tetrahydro-2H-pyran-2-carboxylate. Molecular formula: C19H19NaO8. Mole weight: 398.34. | |
| (2S,3S,4S,5S)-3,4-Dihydroxy-5-(hydroxymethyl)-N-methyl-2-pyrrolidine carboxamide | (2S,3S,4S,5S)-3,4-Dihydroxy-5-(hydroxymethyl)-N-methyl-2-pyrrolidine carboxamide is a compound aiming to modulate precise biochemical pathways. It can be used for the research of combating drug-resistant strains and ailments associated with bacterial and viral contagions. Synonyms: 2-Pyrrolidinecarboxamide, 3,4-dihydroxy-5-(hydroxymethyl)-N-methyl-, (2S,3S,4S,5S)-; (2S,3S,4S,5S)-3,4-Dihydroxy-5-(hydroxymethyl)-N-methyl-2-pyrrolidinecarboxamide. CAS No. 1591783-26-4. Molecular formula: C7H14N2O4. Mole weight: 190.20. | |
| (2S,3S,4S,5S)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate | (2S,3S,4S,5S)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate is a potential drug candidate used in biomedicine for treating cancer. It is a small molecule inhibitor of WEE1, a protein kinase that regulates the G2/M checkpoint of the cell cycle. Inhibition of WEE1 leads to the activation of CDK1 and CDK2, causing DNA damage and cell death in cancer cells. Synonyms: (2S,3S,4S,5S)-5-(4-benzoylamino-2-oxopyrimidine-1(2H)-yl)-2-((benzoyloxy)methyl)-4-Fluoro-4-methyltetrahydrofuran-3-yl benzoate. Grade: 97%. Molecular formula: C31H26FN3O7. Mole weight: 571.55. | |
| (2S,3S,4S,5S,6R)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate | (2S,3S,4S,5S,6R)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C29H33ClO10. Mole weight: 577.02. | |
| (2S,3S,4S)-N-Ethyl-2-hydroxymethyl-3,4-pyrrolidinediol | (2S,3S,4S)-N-Ethyl-2-hydroxymethyl-3,4-pyrrolidinediol is a biomedicine product commonly used in the treatment of various diseases. It has shown promising results in combating neurological disorders, such as Alzheimer's and Parkinson's disease. Additionally, this product has potential therapeutic applications in the field of cancer research due to its anti-tumor properties. Extensive studies have demonstrated its effectiveness in targeting specific cellular pathways involved in disease progression, making it a valuable asset in the biomedical industry. Molecular formula: C7H15NO3. Mole weight: 161.20. | |
| (2S,3S,5R)-3-((1H-1,2,3-Triazol-1-yl)methyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4-oxide | One of the impurities of Tazobactam, which is a β-Lactamase inhibitor and often be used with antibiotics in order to increase their effect. Grade: 95%. CAS No. 904671-24-5. Molecular formula: C10H12N4O4S. Mole weight: 284.29. | |
| (2S,3S,5R)-3-Chloromethyl-3-methyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid benzhydryl ester | One of the impurities of Tazobactam, which is a β-Lactamase inhibitor and often be used with antibiotics in order to increase their effect. Grade: 95%. CAS No. 115546-67-3. Molecular formula: C21H20ClNO3S. Mole weight: 401.9. | |
| (2S,3S)-E1R | (2S,3S)-E1R is an enantiomer of E1R, which is a potential positive allosteric modulator of sigma-1 receptor. Synonyms: (4S,5S)-2-Oxo-4beta-phenyl-5alpha-methylpyrrolidine-1-acetamide. Grade: 98%. CAS No. 1424832-57-4. Molecular formula: C13H16N2O2. Mole weight: 232.28. | |
| (2S,3'S)-Glycopyrrolate Bromide | (2S,3'S)-Glycopyrrolate Bromide is an impurity of Glycopyrrolate, which is an anticholinergic agent with antispasmodic activity used to treat gastrointestinal conditions associated. Synonyms: (3S)-3-[[(2S)-Cyclopentylhydroxyphenylacetyl]oxy]-1,1-dimethylpyrrolidinium Bromide; (3S)-3-[[(2S)-2-Cyclopentyl-2-hydroxy-2-phenylacetyl]oxy]-1,1-dimethylpyrrolidinium Bromide (1:1); Glycopyrrolate Erythro Isomer (SS-Isomer); (S)-3-((S)-2-Cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide; Glycopyrronium Bromide EP Impurity N. Grade: 98%. CAS No. 201667-20-1. Molecular formula: C19H28BrNO3. Mole weight: 398.33. | |
| (2S)-4-biphenyl-4-yl-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide | (2S)-4-biphenyl-4-yl-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide inhibits LpxC with IC50 < 95.2 nM. Grade:>98.0%. CAS No. 1354546-42-1. Molecular formula: C18H21NO4S. Mole weight: 347.43. | |
| 2-[(S)-(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine (2R,3R)-2,3-Dihydroxybutanedioate | An impurity of Bepotastine besylate, a histamine H1 receptor antagonist that has been approved in Japan for the treatment of allergic rhinitis and uriticaria/puritus. Synonyms: 2-[(S)-(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine L-Tartrate. CAS No. 210095-58-2. Molecular formula: C17H19ClN2O.C4H6O6. Mole weight: 452.89. | |
| (2S)-4'-Depropyl-4'-propylidenelincomycin-[d3] | (2S)-4'-Depropyl-4'-propylidenelincomycin-[d3] is the labeled analog of (2S)-4'-Depropyl-4'-propylidenelincomycin, a Lincomycin impurity, an antibiotic produced by Streptomyces lincolnensis. Lincomycin is a lincosamide antibiotic that forms cross-links within the peptidyl transferase loop region of the 23S rRNA. Inhibits bacterial protein synthesis. Antibacterial. Synonyms: (2S)-4'-Depropyl-4'-propylidenelincomycin-d3; Methyl-d3 6,8-Dideoxy-6-[[[(2S)-1-methyl-4-propylidene-2-pyrrolidinyl]carbonyl]amino]-1-thio-D-erythro-α-D-galacto-octopyranoside; Methyl-d3 (2S)-6,8-Dideoxy-6-[[(1-methyl-4-propylidene-2-pyrrolidinyl)carbonyl]amino]-1-thio-D-erythro-α-D-galacto-octopyranoside; (S)-N-((1R,2R)-2-Hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-d3-4-propylidenepyrrolidine-2-carboxamide; 4'-Depropyl-4'-propylidenelincomycin-d3. Molecular formula: C18H29D3N2O6S. Mole weight: 407.54. | |
| (2S,4R)-4-Ethyl-1-methylproline Hydrochloride | (2S,4R)-4-Ethyl-1-methylproline Hydrochloride is a decomposition product of Lincomycin B, an antibiotic. Synonyms: (2S-trans)-4-Ethyl-1-methylproline Hydrochloride; Lincomycin Impurity 2 HCl; (4R)-4-Ethyl-1-methyl-L-proline hydrochloride (1:1); L-Proline, 4-ethyl-1-methyl-, (4R)-, hydrochloride (1:1). Grade: ≥90%. CAS No. 2880-73-1. Molecular formula: C8H16ClNO2. Mole weight: 193.67. | |
| (2S,4R)-4-Ethyl-L-proline Hydrochloride | (2S,4R)-4-Ethyl-L-proline Hydrochloride is a useful amino acid intermediate used in the preparation of Lincomycin, which is a lincosamide antibiotic from the actinomycete Streptomyces lincolnensis. Synonyms: (4R)-4-Ethyl-L-proline hydrochloride (1:1); L-Proline, 4-ethyl-, (4R)-, hydrochloride (1:1); (2S-trans)-4-Ethyl proline Hydrochloride. Molecular formula: C7H14ClNO2. Mole weight: 179.64. | |
| (2S,4'R,8'R)-α-Tocopherol | (2S,4'R,8'R)-α-Tocopherol is one of the 8 stereoisomers contained in the racemic mixture of synthetic α-Tocopherol, a vitamin E substitute. Synonyms: (2S)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol; (2S)-2,5,7,8-Tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-6-chromanol; 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, (2S)-. CAS No. 18920-63-3. Molecular formula: C29H50O2. Mole weight: 430.70. | |
Our database is helping our users find suppliers everyday.
